Exploring the association of adverse drug reactions with medication adherence and quality of life among hypertensive patients: a cross-sectional study
International Journal of Clinical Pharmacy · 2025
DOI: 10.1007/s11096-024-01832-9 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Clinical Pharmacy, 2025. Verfasst von Widya N Insani und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Clinical Pharmacy, Padjadjaran University, Bandung, Indonesia. Hauptthemen laut MEDLINE: Quality of Life, Hypertension, Antihypertensive Agents, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lembaga Pengelola Dana Pendidikan.
Abstract (Originalsprache)
Background
Effective hypertension management requires medication adherence to prevent complications. However, adverse drug reactions (ADRs) can undermine adherence and negatively affect patients’ quality of life. Limited research has explored the association between ADRs, medication adherence, and health-related quality of life (HRQoL) in individuals with hypertension.
Aim
To investigate the association between ADRs, medication adherence, and HRQoL among patients with hypertension.
Method
A cross-sectional study using telephone interviews and medical record reviews was conducted in 11 primary care facilities in Indonesia. The causality of reported ADRs was assessed using the Naranjo algorithm, validated by a panel of experts in pharmacy practice and medication safety. The severity of ADRs was classified using the Hartwig scale. Adherence to antihypertensive drugs was estimated using the Medication Adherence Report Scale-5 (MARS-5). The EuroQoL EQ-5D-5L was used to measure HRQoL. The association between ADRs and medication adherence was assessed using multivariate logistic regression, while the association with HRQoL was evaluated through the Tobit regression model.
Results
A total of 507 patients were included in this study. We found that 20.32% (n = 103) of the patients experienced ADRs, with the most commonly reported ADRs being polyuria and urgency, gastrointestinal symptoms, leg swelling, dizziness/hypotension, palpitations, and dry cough. The majority experienced mild ADRs (n = 75, 72.82%), while 27.18% (n = 28) had reactions of moderate severity. Experiencing ADRs was associated with reduced medication adherence (adjusted odds ratio (OR) 7.15, 95% CI 4.07–12.55) and decreased HRQoL (coefficient: − 0.037).
Conclusion
Patients experiencing ADRs were seven times more likely to be non-adherent to their medication regimen and reported a reduced quality of life compared to those without ADRs, placing them at a higher risk of suboptimal treatment outcomes. This finding highlights the need for additional monitoring and education for patients affected by ADRs, particularly through more frequent clinical and laboratory assessments, timely management of ADRs, and personalized education on the importance of adherence to prevent hypertension-related complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Clinical Pharmacy, Padjadjaran University, Bandung, Indonesia.
- Centre of Excellence for Pharmaceutical Care Innovation, Padjadjaran University, Bandung, Indonesia.
- Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK.
- Centre for Medicines Optimisation Research and Education, University College London Hospitals NHS Foundation Trust, London, UK.
- Division of Nephrology and Hypertension, Department of Internal Medicine, Faculty of Medicine, Padjadjaran University, Hasan Sadikin General Hospital, Bandung, Indonesia.
- Department of Biomedical Sciences, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia.
Förderung
- Lembaga Pengelola Dana Pendidikan
Zitieren
APA
Insani, W. N., Wei, L., Abdulah, R., Alfian, S. D., Ramadhani, N. A., Andhika, R., Zakiyah, N., Adesuyan, M., Pamela, Y., Mustafa, R., & Whittlesea, C. (2025). Exploring the association of adverse drug reactions with medication adherence and quality of life among hypertensive patients: a cross-sectional study. International Journal of Clinical Pharmacy. https://doi.org/10.1007/s11096-024-01832-9
Vancouver
Insani WN, Wei L, Abdulah R, Alfian SD, Ramadhani NA, Andhika R, et al. Exploring the association of adverse drug reactions with medication adherence and quality of life among hypertensive patients: a cross-sectional study. International Journal of Clinical Pharmacy. 2025. doi:10.1007/s11096-024-01832-9
BibTeX
@article{Insani2025,
author = {Insani, Widya N and Wei, Li and Abdulah, Rizky and Alfian, Sofa D and Ramadhani, Nurul A and Andhika, Rizky and Zakiyah, Neily and Adesuyan, Matthew and Pamela, Yunisa and Mustafa, Rima and Whittlesea, Cate},
title = {Exploring the association of adverse drug reactions with medication adherence and quality of life among hypertensive patients: a cross-sectional study},
journal = {International Journal of Clinical Pharmacy},
year = {2025},
doi = {10.1007/s11096-024-01832-9}
}
EUVIMED